London to issue positive immunity certificates
The need for an exit strategy from the epidemic pushes the Government to search for a reliable antibody test
The British Government is considering the possibility of issuing immunity certificates to those who test positive on the Covid-19 antibody tests. The ‘passport’ would serve as presumable controls in the companies, intended to encourage employees with apparent immunity against the virus to work and for those who have not been infected to take precautions.
The Health Minister, Matt Hancock, has confirmed that the delivery of some type of document is part of the ideas that the British Government is considering for the call. ‘Exit strategy’ of the epidemic. Protagonists of the 2008 financial crisis have asked the Government to apply itself now in the design of that plan so that the damage to the country’s economy and its consequences do not spread without horizon.
The documentary part of the strategy depends on the existence of a reliable antibody test, which at the moment does not have any country from the Group of Seven. The British Ministry of Health has tested several tests and purchased millions, but none have been certified so far. Hancock claims they have only spent money paying for the samples.
- Sweden is the pilot experience of another way to combat the epidemic
The antibody test is theoretically simpler than the one that checks the presence of the virus in the serum. It could be produced in large quantities and the results would be faster. Public health spokespersons insist that much preparatory work is being carried out and that the reliability of the test is essential.
The logistics for carrying out millions of tests that would facilitate the return to social and economic activity is complicated. The British Government has been criticized for its delay in reaching test figures in patients and medical personnel, but it is concealed in that it did not have a significant industrial diagnostics sector and that three large test centers are being built in a very short time.
A sample is being carried out that could soon give an approximation of the percentage of the population that has been infected and has been cured, but conducting antibody tests on millions of people could change the orientation of measures, pending a vaccine.